China Biologic Produ (CBPO)
$117.89 0.04 (0.03%)
10:05 EST CBPO Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 3.21B
PE Ratio 52.63
Volume (Avg. Vol.) 4,225
Day's Range 117.60 - 118.01
52-Week Range 97.91 - 120.01
Dividend & Yield N/A (N/A)
CBPO Stock Predictions, Articles, and China Biologic Produ News
- From InvestorPlace
- From the Web
It’s a good time to separate the weak from the strong.
Many of these biotech companies are beating the Nasdaq Biotech Index. With cutting-edge therapies, these are great names to buy.
25 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
The grades of 13 Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
The following stocks were moving the Manufacturing sector today.
The grades of 3 Biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Here are my 40 top growth stocks that meet the metrics in the Portfolio Grader system...
Healthcare has been a top performing industry this year, and long-term growth in services, technological advances make these are some of the best healthcare stocks to buy for the long haul.
Healthcare stocks rose 0.5% on Wall Street on Friday.
Healthcare stocks rose broadly on Wall Street on Wednesday morning, with the sector seeing an overall increase of 0.7%.
Healthcare stocks declined on Wall Street on Tuesday, down 2.4%.
Healthcare stocks rose 1.8% on Wall Street on Wednesday morning.
This week, these ten stocks, all currently earning A's ("strong buy") on Portfolio Grader, have the best year-to-date performance.
Healthcare stocks declined 0.3% on Wall Street today.
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader